Target Details
| UniProt AC | Q07889 |
|---|---|
| Gene Symbol | SOS1 |
| Protein Name | Son of sevenless homolog 1 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00617 (RasGEF) PF00618 (RasGEF_N) PF00621 (RhoGEF) PF22697 (SOS1_NGEF_PH) |
Summary
- Multi-target molecules 766
- Clinical molecules 0
- Avg pChEMBL 8.12
KEGG Pathways (48)
- Acute myeloid leukemia
- Alcoholism
- B cell receptor signaling pathway
- Breast cancer
- Chemical carcinogenesis - reactive oxygen species
- Chemical carcinogenesis - receptor activation
- Chemokine signaling pathway
- Choline metabolism in cancer
- Chronic myeloid leukemia
- Colorectal cancer
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Endometrial cancer
- ErbB signaling pathway
- Estrogen signaling pathway
- Fc epsilon RI signaling pathway
- Focal adhesion
- FoxO signaling pathway
- Gap junction
- Gastric cancer
- Glioma
- GnRH signaling pathway
- Growth hormone synthesis, secretion and action
- Hepatitis B
- Hepatitis C
- Hepatocellular carcinoma
- Human cytomegalovirus infection
- Human papillomavirus infection
- Insulin signaling pathway
- JAK-STAT signaling pathway
- MAPK signaling pathway
- MicroRNAs in cancer
- Natural killer cell mediated cytotoxicity
- Neurotrophin signaling pathway
- Non-small cell lung cancer
- PI3K-Akt signaling pathway
- Pathways in cancer
- Phospholipase D signaling pathway
- Prolactin signaling pathway
- Prostate cancer
- Proteoglycans in cancer
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Relaxin signaling pathway
- Renal cell carcinoma
- T cell receptor signaling pathway
- Thermogenesis
- mTOR signaling pathway
Associated Diseases (3)
Active Molecules (766)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
SXVGKYSBFKPTPK
|
8.1 | IC50 | 2 | — | |
WPOBEZNKZFBFEU
|
8.1 | IC50 | 2 | — | |
WZWBSPDLOXVJLE
|
8.1 | IC50 | 2 | — | |
YOGYJXUZDPJXCR
|
8.1 | IC50 | 2 | — | |
ZCXDDJLWNVDNIJ
|
8.1 | IC50 | 2 | — | |
VZKVBOSZPUCSPC
|
8.0 | Kd | 2 | — | |
ZTRVEWBYFXWLAB
|
8.0 | Kd | 2 | — | |
BOTSWRIBHONRLE
|
8.0 | IC50 | 2 | — | |
PTQJSAPNZBKBNS
|
8.0 | IC50 | 2 | — | |
AKTPNGKZOWPQBV
|
8.0 | IC50 | 2 | — | |
CMGOTJGHHUCXLX
|
8.0 | IC50 | 2 | — | |
FHZZXSKTEWEEBO
|
8.0 | IC50 | 2 | — | |
HESOTLVDNGLZLF
|
8.0 | Kd | 2 | — | |
JFKYVJBTMFQCQA
|
8.0 | Kd | 2 | — | |
KAKAASNFGCUXST
|
8.0 | IC50 | 2 | — | |
MBAZIYTXPLHJGC
|
8.0 | IC50 | 2 | — | |
MYTPKSVWVNSKIT
|
8.0 | IC50 | 2 | — | |
PDSRJRWWJSNRKZ
|
8.0 | IC50 | 2 | — | |
QCCGUNMXGSHAPH
|
8.0 | IC50 | 2 | — | |
WHNMPIOAEAZFLA
|
8.0 | IC50 | 2 | — | |
YLMXDBIDMIUTBC
|
8.0 | Kd | 2 | — | |
YMJMARPKWPPUAP
|
8.0 | IC50 | 2 | — | |
YPDNAZOMTVNVDU
|
8.0 | Kd | 2 | — | |
ZPMRFCQXYVPXPD
|
8.0 | Kd | 2 | — | |
CJXQWWJHPSZRKY
|
8.0 | Kd | 2 | — | |
HTIDHSSEZIZOAR
|
8.0 | IC50 | 2 | — | |
SSHVSGVCFOJJAC
|
8.0 | Kd | 2 | — | |
HEJBSQISDYWROA
|
8.0 | Kd | 2 | — | |
AUNKFAYXAUMFET
|
8.0 | IC50 | 2 | — | |
GUPWSNZZMHQDIJ
|
8.0 | Kd | 2 | — | |
IJCLHJOQUAPPBT
|
8.0 | IC50 | 2 | — | |
OPWSDOPRIRMMJL
|
8.0 | IC50 | 2 | — | |
PWDZLPJWLUSWSR
|
8.0 | IC50 | 2 | — | |
QHWSZCUFLFXHGI
|
8.0 | Kd | 2 | — | |
RHPHHDQALDSEBF
|
8.0 | IC50 | 2 | — | |
UEUWODMLLMTHCZ
|
8.0 | IC50 | 2 | — | |
WBANNPWGKBSAHA
|
8.0 | IC50 | 2 | — | |
WBEQVQFNLGSLAA
|
8.0 | IC50 | 2 | — | |
WOFRLOJQAVLOPQ
|
8.0 | IC50 | 2 | — | |
XHKJENSQDYMNJN
|
8.0 | IC50 | 2 | — | |
XWUVXZLOVONISO
|
8.0 | Kd | 2 | — | |
YZCUHQHANBCQDM
|
8.0 | Kd | 2 | — | |
ZHSXPMMUWCQAEC
|
8.0 | Kd | 2 | — | |
NKXYOKLDTJGMLK
|
7.9 | IC50 | 2 | — | |
AFVPWZOZQGBQMX
|
7.9 | IC50 | 2 | — | |
CAAUVYVMRBTGNN
|
7.9 | IC50 | 2 | — | |
DCLNSQPAWAPUAP
|
7.9 | Kd | 2 | — | |
FGLXKUHVGMKXBU
|
7.9 | IC50 | 2 | — | |
GBWNFEGPQDPVBL
|
7.9 | Kd | 2 | — | |
KIJQQWFQCUSEAU
|
7.9 | Kd | 2 | — |